After completing this activity, pharmacists should be able to:
- Describe the potential use of chloroquine and its analogues for the treatment of COVID-19
- Outline current regulatory restrictions around the prescribing and dispensing of hydroxychloroquine
The 2016 Competency Standards addressed by this activity include: 1.2, 1.3, 3.1, 3.2, 3.5, 3.6
Accreditation number: A2004COVID19-3 Accreditation expires: 31/08/2020
This activity has been accredited for 1 hour of Group One CPD (or 1 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 1 hour of Group Two CPD (or 2 CPD credits) upon successful completion of the associated assessment activity.